![]()
|
Report Date : |
05.09.2008 |
IDENTIFICATION
DETAILS
|
Name : |
DAWA
LIMITED |
|
|
|
|
Registered Office : |
P.O. Box 16633-00620 , Nairobi |
|
|
|
|
Country : |
Kenya |
|
|
|
|
Date of Incorporation : |
05.08.2004 |
|
|
|
|
Com. Reg. No.: |
111518. Nairobi, Kenya |
|
|
|
|
Legal Form : |
Limited Liability Company, Limited by Shares |
|
|
|
|
Line of Business : |
Manufacturer of Drugs and Pharmaceuticals Products. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 100,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
DAWA
LIMITED
P.O. BOX 16633-00620 , Nairobi, Kenya
Telephone: +254-20-802404/
6752740
Fax: +254-20-861550/
803996
Email: dawa@africaonline.co.ke
5th August, 2004
No.111518.
Nairobi, Kenya
Limited Liability
company, Limited by shares
Not Listed
2007
65
Head offices LR 1870/111/
164 CNR Brook side Drive, Brook side Garden
Branches None.
Paid in Capital KShs. 100,000
Subscribed Capital KShs. 100,000
Name Position Amount
Ratio
Mrs. Reema shah Managing Director 100 1.00%
Medisel (K) Ltd Holding Co. 9,900 99.00%
Total 10,000 100.00%
Our proposed
credit amount of USD 100,000 is recommendable
Company (1) UNICORN PHARMA (K) LTD
|
President/
CEO (1) |
|
|
Name |
Mrs. Reema shah |
|
Work Experience |
12 years in this line of business |
|
Remarks |
Top Decision Maker |
Manufacturer of
drugs and pharmaceuticals products.
Buying terms 30%
in cash, 70% on credit
Selling terms 80% in cash, 20% on credit
Universal Corporation
Wholesalers, retailers,
pharmacies, hospitals etc
KSHS. 218,000,000
(2007)
Uganda And
Tanzania
20.0%
60.0%
52.0%
Main Banks I&M BANK LTD,
Nairobi, Kenya
Payment Morale: In the documents at our
disposal nothing adverse has been shown so far.
CREDIT RATING: Financial situation is
average.
Maximum credit we recommend is USD 100,000 outstanding at any one time.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.37 |
|
UK Pound |
1 |
Rs.78.09 |
|
Euro |
1 |
Rs.63.41 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to
assess SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial condition (40%) Ownership background (20%) Payment
record (10%)
Credit history (10%) Market trend (10%) Operational
size (10%)